The involvement of ABC transporters, particularly MDR1 (ABCB1), MRP1 (ABCC1) and BCRP (ABCG2), in resistance to traditional chemotherapy has been well established in bladder cancer. This evidence concerns the gene ABCG2 and urinary bladder carcinoma.